Valley Diagnostics develops lateral flow test kits that utilize patented biomarker signatures for the early detection of diseases such as prostate and lung cancer, as well as bovine tuberculosis. Their smartphone-enabled platform captures and analyzes test results, facilitating timely diagnosis and improved health outcomes for both humans and animals.
Funding
$320K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting diseases like prostate and lung cancer, as well as bovine tuberculosis, often lack the speed and accessibility needed for early diagnosis, hindering timely intervention and improved health outcomes. Traditional diagnostic processes can be slow, require specialized equipment, and may not be readily available in point-of-care or field settings.
Solution
Valley Diagnostics develops rapid, point-of-care lateral flow test kits for the early detection of diseases, including prostate and lung cancer in humans, and bovine tuberculosis in animals. These kits utilize patented biomarker signatures to identify diseases at an early stage. The company's smartphone-enabled platform, called Transform, captures and analyzes test results, providing a comprehensive solution for data capture, analysis, reporting, and recording of lateral flow test results. This integrated approach facilitates faster diagnosis and enables healthcare systems and veterinary professionals to make more informed decisions, leading to better patient and animal outcomes.
Target Audience
The primary target audience includes healthcare systems, veterinary professionals, and researchers focused on early disease detection and improved diagnostic outcomes for both human and animal health.
Features
- Lateral flow assays utilizing patented biomarker signatures for early disease detection.
- Prostate Cancer Test: A rapid point-of-care screening test for early and faster diagnosis.
- Lung Cancer Test: A rapid point-of-care screening test for early and faster diagnosis.
- Bovine TB Test: A rapid point-of-use lateral flow test for use in the field.
- Transform: A smartphone and cloud-based platform for capturing, analyzing, reporting, and recording lateral flow test results.
- AI-powered digital smartphone reader for accurate test result interpretation.
- Data management software platform built to Software as a Medical Device (“SaMD”) standard for regulatory compliance.